The Marlborough, Mass.-based company’s device is a visually-guided balloon catheter that uses a rotating laser to ablate the tissue surrounding the pulmonary artery’s entrance into the heart, to reduce atrial fibrillation.
The Bedford, Mass.-based company said the deal, expected to close before the end of the month, will see substantially all of the assets of the seven-year-old catheter business go to Salt Lake City-based Bard, in return for $14.9 million in cash and $100,000 to two employees as compensation for non-compete contracts.
Three of the four complaints, one for each lot, did not involve what the company called “adverse patient effects.” However, one complaint showed evidence that the patient suffered a post-procedure heart attack, but was subsequently said to be “doing well,” according to a press release.
Abbott spokesman Jonathon Hamilton told MassDevice that the total number of catheters in all four lots numbers about 550.
The Marlborough cardiac device maker said the system consists of a micro-endoscope physicians use to see within the heart and direct energy through a catheter to the fibrillating tissue in the heart’s atrial chamber.
The Marlborough device maker is developing a catheter-based system that uses lasers to treat atrial fibrillation. It’s currently in pre-marketing clinical trials under an investigational device exemption from the Food & Drug Administration.
The Wilmington radio frequency generator manufacturer said the deal extends its reach into the interventional pain management market.
Micron Catheter makes an epidural catheter used to remove scar tissue formed after back surgeries.
InfraReDx Inc.‘s optical/acoustic imaging catheter was used for the first time in patients undergoing angiography in the Netherlands.
The Burlington-based near-infrared spectroscopy maker said the device, which uses both ultrasound waves and near-infrared light to provide images of the coronary plaque believed to cause most heart attacks, can help surgeons determine not only the shape of the plaque but its composition.
That means the device can help doctors assess the likelihood of further cardiovascular problems stemming from the plaque lining patients’ blood vessels.
The federal watchdog agency said it received 25 complaints, but no reports of injuries, about a problem it described as a faulty volume connection for the Everett-based company’s 30cc, 40cc and 50cc Intra Aortic Balloon Pump catheters made by its Arrow International subsidiary.
Boston Scientific Corp.’s iCross coronary imaging catheter hit the United States market March 19, two days after the company said two of its new drug coated stents should debut in Europe later this year — possibly earlier in non-EU countries.
The Natick medical device colossus said its iCross coronary imaging catheter, designed for use with its intravascular ultrasound iLab imaging system, is now available in the U.S.
The Burlington-based startup plans to use its Small Business Innovation Research grant to develop its electronic catheter, which is designed to map the heart and its electrical activity during catheter ablations, in which surgeons remove the damaged cardiac tissue that causes arrhythmia, or irregular heartbeats.